We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+1.87%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$1.51B
AUM Growth
-$409M
Cap. Flow
-$427M
Cap. Flow %
-28.33%
Top 10 Hldgs %
28.77%
Holding
232
New
58
Increased
45
Reduced
50
Closed
68

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$31.1M
2
TDG icon
TransDigm Group
TDG
+$24M
3
MRK icon
Merck
MRK
+$18.9M
4
MSFT icon
Microsoft
MSFT
+$17.8M
5
ON icon
ON Semiconductor
ON
+$16.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.84%
2 Technology 16.02%
3 Financials 15.78%
4 Communication Services 15.65%
5 Consumer Discretionary 11.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALDR
51
DELISTED
Alder Biopharmaceuticals
ALDR
$9.74M 0.65%
468,435
+294,035
+169% +$7.65M
BIDU icon
52
Baidu
BIDU
$30.8B
$9.6M 0.64%
+58,400
New +$9.94M
PFE icon
53
Pfizer
PFE
$157B
$9.56M 0.63%
310,298
+293,012
+1,695% +$8.95M
LN
54
DELISTED
LINE Corporation
LN
$8.67M 0.57%
+254,900
New +$10.1M
MXL icon
55
MaxLinear
MXL
$6.09B
$8.59M 0.57%
393,800
+102,900
+35% +$2.13M
TWO
56
DELISTED
Two Harbors Investment
TWO
$8.57M 0.57%
122,913
-153,812
-56% -$10.5M
CORV
57
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$8.45M 0.56%
3,061,064
BMRN icon
58
BioMarin Pharmaceuticals
BMRN
$12.5B
$8.09M 0.54%
97,709
+33,509
+52% +$2.88M
VRTX icon
59
Vertex Pharmaceuticals
VRTX
$130B
$8.06M 0.53%
109,348
+44,448
+68% +$3.62M
HPE icon
60
Hewlett Packard
HPE
$74.2B
$7.84M 0.52%
+582,753
New +$7.78M
MTGE
61
DELISTED
MTGE Investment Corp. Common Stock
MTGE
$7.66M 0.51%
487,904
-699,324
-59% -$11.6M
W icon
62
Wayfair
W
$14.2B
$7.65M 0.51%
218,182
-12,018
-5% -$432K
SIG icon
63
Signet Jewelers
SIG
$3.83B
$7.39M 0.49%
78,374
+12,226
+18% +$1.07M
BEN icon
64
Franklin Templeton
BEN
$16.9B
$7.35M 0.49%
+185,800
New +$6.96M
DERM
65
DELISTED
Dermira, Inc.
DERM
$6.99M 0.46%
230,585
+80,901
+54% +$2.61M
CRM icon
66
Salesforce
CRM
$210B
$6.58M 0.44%
96,100
+23,800
+33% +$1.73M
AKRX
67
DELISTED
Akorn Inc
AKRX
$6.2M 0.41%
283,971
-97,648
-26% -$2.25M
BSX icon
68
Boston Scientific
BSX
$63.6B
$6.08M 0.4%
281,225
+257,700
+1,095% +$5.62M
MNRO icon
69
Monro
MNRO
$391M
$6M 0.4%
104,800
+7,400
+8% +$426K
LVS icon
70
Las Vegas Sands
LVS
$26.7B
$5.98M 0.4%
+112,028
New +$6.53M
JAZZ icon
71
Jazz Pharmaceuticals
JAZZ
$15.6B
$5.68M 0.38%
+52,100
New +$5.8M
PE
72
DELISTED
PARSLEY ENERGY INC
PE
$5.68M 0.38%
161,167
-629,433
-80% -$22.3M
XRN
73
Chiron Real Estate Inc
XRN
$478M
$5.58M 0.37%
125,000
WVE icon
74
Wave Life Sciences
WVE
$879M
$5.52M 0.37%
211,103
-35,800
-14% -$1.16M
SUNS
75
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
$5.51M 0.37%
335,378
+43,378
+15% +$702K

Similar funds

Clough Capital Partners's Q4 2016 Portfolio in Review

As of Q4 2016, Clough Capital Partners held 232 positions worth $1.51B, down 21% from $1.92B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Clough Capital Partners withdrew a net $427M in Q4 2016, closing 68 positions and reducing 50 holdings. Its most notable exit was AGNC Investment, an estimated $37.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

Against the trend, Clough Capital Partners opened a new position in TransDigm Group worth $22.7M.

  • Clough Capital Partners's largest Q4 2016 buy was TransDigm Group: 91,300 shares worth $22.7M.
  • Clough Capital Partners added most to Apple in Q4 2016, an estimated $31.1M increase.
  • Clough Capital Partners's biggest Q4 2016 reduction was Alphabet (Google) Class C, cutting an estimated $41.5M.
  • Clough Capital Partners fully exited AGNC Investment in Q4 2016, selling an estimated $37.4M.
  • Clough Capital Partners's ten largest holdings make up 29% of its $1.51B portfolio in Q4 2016.
  • Clough Capital Partners opened 58 new positions and closed 68 in Q4 2016.
  • Clough Capital Partners's portfolio value fell 21% quarter-over-quarter to $1.51B.

Based on Clough Capital Partners's 13F filing for Q4 2016, filed 14 Feb 2017.